GOVX:NASDAQ
Geovax Labs Inc
$0.35
arrow_downward
-1.51%(-0.0053) 1D
$0.36
arrow_upward
+2.83% (+0.0098)todayPre-market
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.36
High
$0.37
Low
$0.34
Mkt. cap
3.15M
Avg. vol.
954.20K
Volume
1.29K
52-wk high
$16.50
52-wk low
$0.34
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
Open
$0.36
High
$0.37
Low
$0.34
Mkt. cap
3.15M
Avg. vol.
954.20K
Volume
1.29K
52-wk high
$16.50
52-wk low
$0.34
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
GOVX Q2 2026 Earnings: Narrower-than-expected loss highlights cost discipline amid developmental stage - Return On Equity
https://www.dars.gov.et/
·
2 months ago
GOVX Q1 2026 Earnings: Narrower Loss Beats Estimates as GeoVax Advances Vaccine Pipeline - Revenue Growth Report
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com